UC Davis Health awarded more than $390,000 through its STAIR HEALTH proof-of-concept program to support three interdisciplinary research teams advancing promising innovations in cancer imaging, spinal cord injury treatment and breast cancer therapeutics toward commercial and clinical impact.
UC Davis Health Ventures, part of the Innovation and Economic Development Office at UC Davis, today announced the appointment of Troels Adrian as Director of Industry Engagement.
UC Davis showcased groundbreaking translational research and innovative biotech startups at the 8th Annual Biotech Innovation Gallery in San Francisco. Hosted by the UC Davis Innovation and Economic Development Office, the event brought in over 330 attendees to connect with and explore potential partnerships with researchers and startup founders, aligning with the J.P. Morgan Healthcare Conference.
UC Davis Health Ventures, part of the Innovation and Economic Development Office (IEDO) at the University of California, Davis, today announced the first investment from its Investing in the Future of Medicine (IFM) Fund, backing Delix Therapeutics.
Andrew Brown of UC Davis Health Ventures shares his thoughts on the creation and launch of the TRIage Innovation Forum—an engaging, rapid-pitch platform that helps researchers present their work in three minutes and receive tailored guidance, resources and connections to accelerate the translation of their innovations into real-world health solutions.
UC Davis saw a 34% increase in records of invention in FY 2025, driven largely by health-related innovations and first-time contributors, reflecting a growing culture of commercialization and cross-campus collaboration led by the Innovation and Economic Development Office.
UC Davis strengthens its global life sciences ecosystem with strategic partnerships with FLANN Inc. and HM Venture Partners, aiming to attract international biotech startups to Aggie Square and accelerate the commercialization of groundbreaking healthcare innovations.
